LEXX Lexaria Bioscience 8-K2020Regulation FD Disclosure
31 Dec 20
Content Analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
|
|
LEXX 8-K Filings
- 14 Jan 21 Lexaria Bioscience Corp. Announces Uplisting to Nasdaq Capital Market and Pricing of $9.6 Million Upsized Public Offering
- 31 Dec 20 Regulation FD Disclosure
- 22 Dec 20 Regulation FD Disclosure
- 10 Dec 20 Lexaria Closes Sale of Non-Pharmaceutical THC-Related Assets
- 2 Dec 20 Lexaria’s Patented Technology Significantly Enhances Oral Delivery of Antiviral Drugs
Filing View
Search this filing
Table of Contents
Get all this for free
- Email alerts for new filings that match keywords or companies
- Plot, compare & download financial data
- 10-K & 10-Q redlined comparisons
- Advanced filing search & analysis
- Sentiment analysis for financial filings
- Favorites, search history, and more…